Share
340 Posts.
lightbulb Created with Sketch. 27
clock Created with Sketch.
21/03/23
12:53
Share
Originally posted by hotdogrob:
↑
CHM have a long long long road ahead of themselves and the market knows this.. CHM will need to do many CRs b4 any revenue if at all is realised..and the market knows this.. The market clearly knows there is no rush to buy onto this company just yet..all my opinion of course again my opinion the sp will get worse b4 it gets better..long term view may not matter..and an emphasis on the word MAY is one of the reasons I believe the sp will get worse b4 it gets better keep safe and as always dyor..just my opinion and never advice
Expand
The value of these biotechs is based on optionality before cash flows. So when I feel negative about the share price - it's ultimately up to the potential success of the technology that determines the value.